Medido el 2026-07-09 · DNS público
¿Está iuct-oncopole.fr protegido contra la suplantación de correo?
Todavía no — iuct-oncopole.fr solo observa (p=none); el correo suplantado aún puede entregarse.
Más protegido que el 71 % de sante en Francia
El 0 % del sector ya aplica p=reject
D
DMARC
p=none
SPF
-all
DKIM
ninguno encontrado
Cómo corregirlo
Thomas, tu CISO virtual con IA, identifica cada fuente, escribe el DNS exacto y lleva tu dominio de p=none a p=reject con total seguridad.
Registro publicado
v=DMARC1; p=none; rua=mailto:bxyyanbki7@rua.powerdmarc.com; ruf=mailto:bxyyanbki7@ruf.powerdmarc.com;Qué significa esto
- • Politique p=none : surveillance seule, aucun message non authentifié n'est bloqué.
- • Aucune clé DKIM trouvée sur les sélecteurs courants (le domaine peut utiliser des sélecteurs non standards).
Historial
- 2026-07-09Primera mediciónSolo observación (p=none)
Sobre Oncopole Chu Toulouse
The Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT-Oncopole) is a French healthcare institution specialized in the management of cancer-related conditions. It was formed through the merger of the Centre Hospitalier Universitaire (CHU) de Toulouse and the Institut Claudius Regaud, a cancer treatment center historically established in the region. This association brought together the university hospital's clinical resources with the specialized oncology expertise of the former regional center, aiming to consolidate cancer-related care, research, and teaching activities within a single site.
Located in the Oncopole district in southwestern Toulouse, on the site of the former AZF factory, the institution is part of a broader biomedical cluster gathering several organizations dedicated to oncology, fundamental and clinical research, as well as life sciences industry activities. This location fosters functional proximity between medical teams, researchers, and academic or industrial partners working in the field of cancer.
IUCT-Oncopole provides care covering a wide range of cancer types, offering diagnostic, treatment, and follow-up pathways for adult patients. It also engages in clinical and translational research activities, contributing to the development of new therapeutic approaches, along with teaching and training missions for healthcare professionals. As a regional reference center, it holds an important position in the organization of cancer care across southwestern France, working alongside other hospital institutions and research structures in the area. The website iuct-oncopole.fr is the institution's official site, presenting its missions, organization, and care and research activities, along with practical information for patients and healthcare professionals.